Progression to colectomy in the era of biologics: A single center experience with pediatric ulcerative colitis
Clinical outcomes in pediatric ulcerative colitis (UC) in the era of biologic agents are poorly defined. We aimed to describe risk factors for colectomy in pediatric UC in the era of infliximab therapy.
Source: Journal of Pediatric Surgery - Category: Surgery Authors: Faith D. Ihekweazu, Tatiana Fofanova, Ryan Palacios, Avanthi Ajjarapu, Lina Karam, Adam M. Vogel, J R Rodriguez, Richard Kellermayer Source Type: research
More News: Colectomy | Inflammatory Bowel Disease | Pediatrics | Remicade | Surgery | Ulcerative Colitis